Kazalo 
 Prejšnje 
 Naslednje 
 Celotno besedilo 
Postopek : 2018/2775(RSP)
Potek postopka na zasedanju
Potek postopka za dokument : B8-0071/2019

Predložena besedila :

B8-0071/2019

Razprave :

PV 12/02/2019 - 24
CRE 12/02/2019 - 24

Glasovanja :

PV 13/02/2019 - 16.11
CRE 13/02/2019 - 16.11
Obrazložitev glasovanja

Sprejeta besedila :

P8_TA(2019)0113

Razprave
Sreda, 13. februar 2019 - Strasbourg Pregledana izdaja

16.11. Uporaba konoplje v zdravstvene namene (B8-0071/2019) (glasovanje)
Video posnetki govorov
PV
 

- Prima della votazione sull'emendamento 11:

 
  
MPphoto
 

  Luke Ming Flanagan (GUE/NGL). – Mr President, the reason for the oral amendment is we have left two members of the cannabis family out of what should have been there. It should also include cannabis indica and cannabis ruderalis. Cannabis ruderalis has very low amounts of tetrahydrocannabinol (THC) in comparison to cannabidiol, which is what some people want here and cannabis indica has a better balance of cannabidiol with THC, so if you want to do it right, include this.

 
  
MPphoto
 

  Dubravka Šuica, on behalf of the PPE Group. – Mr President, on behalf of the PPE Group, I object to this oral amendment.

 
  
 

(L'emendamento orale non è accolto vista l'opposizione di oltre 40 deputati presenti in aula)

 
Zadnja posodobitev: 24. maj 2019Pravno obvestilo